MBOT
Microbot Medical Inc

17,831
Mkt Cap
$137.67M
Volume
2.04M
52W High
$4.67
52W Low
$0.89
PE Ratio
-3.57
MBOT Fundamentals
Price
$2.05
Prev Close
$2.03
Open
$2.00
50D MA
$3.02
Beta
1.38
Avg. Volume
2.88M
EPS (Annual)
-$0.7314
P/B
2.56
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)
Microbot Medical (MBOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks·11d ago
News Placeholder
More News
News Placeholder
Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval
STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.
Zacks·20d ago
News Placeholder
All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy
Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·1mo ago
News Placeholder
Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System
MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.
Zacks·2mo ago
News Placeholder
Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market
MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.
Zacks·3mo ago
News Placeholder
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?
Zacks·5mo ago
News Placeholder
Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus
Zacks·5mo ago
News Placeholder
Stocktwits Poll: Retail Investors Bet RR Stock Will Have Most Upside In 2025 Among Robotics Players
Richtech Robotics lost nearly 59% of its market capitalization in the period, compared to SERV's nearly 28% loss and MBOT's 43% gain.
Stocktwits·10mo ago
News Placeholder
Microbot Medical Gets Quality Certification for its System
Microbot Medical Inc. (NASDAQ: MBOT) recently announced the receipt of ISO 13485:2016 certification for its quality management system. read more...
Benzinga·1y ago
News Placeholder
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this applicationBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot...
Globe Newswire·2y ago

Latest MBOT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.